Skip to main content

This is a prototype for user testing.

Topic taxonomy suggestions experiment

MHRA approves sebetralstat (Ekterly) to treat hereditary angioedema (HAE) attacks in patients aged 12 and over

View document on GOV.UK (opens in new tab)

Existing topic taxonomy tags

Tags already associated with the document.

Suggested topic taxonomy tags

Tags which are used on similar documents.

Similar documents

The documents from which the suggested topic taxonomy tags are derived.

  1. Garadacimab (andembry) approved to prevent angioedema attacks
  2. Sebetralstat in the treatment of hereditary angioedema (HAE) attacks
  3. MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP) 
  4. Efanesoctocog alfa approved to prevent and treat bleeding in children and adults with severe or moderate haemophilia A
  5. MHRA approves teprotumumab as the first UK treatment for adults with moderate to severe Thyroid Eye Disease (TED)